Sermorelin vs ipamorelin: which is better?

Neither is "better" outright — they hit different receptors. Sermorelin is a GHRH analog (it pushes the pituitary the way the hypothalamus does); ipamorelin is a ghrelin-receptor agonist (it pushes the same pituitary cells through a separate channel). For most strength and recovery users, ipamorelin paired with CJC-1295 produces cleaner, more predictable GH pulses. Sermorelin shines in specific cases — older users, people who want a more "physiologic" pattern, and prescription-channel access.

The mechanism difference

Both compounds make your pituitary release growth hormone, but through different doors.

The two pathways are complementary, which is why almost every "real" GH secretagogue protocol combines a GHRH (sermorelin or CJC-1295) with a GHRP (ipamorelin most commonly). Pairing produces a synergistic pulse that single-agent dosing does not.

What "better" actually means by goal

For sleep, recovery, and body composition: Ipamorelin + CJC-1295 (mod GRF 1-29 or DAC) is the dominant stack. Cleaner pulses, longer-lasting GHRH support, no cortisol confound.

For prescription-channel access: Sermorelin has a longer history with US compounding pharmacies. Ipamorelin sits firmly in the research-chemical tier. If your goal is a regulated supply chain with a clinician overseeing it, sermorelin is the more accessible option.

For older users (50+) with declining GH output: Sermorelin's GHRH-side action may be the more "physiologic" fit because it works with the hypothalamic-pituitary axis the way the body does naturally. Many anti-aging protocols default to sermorelin for this reason.

For training-focused users (lifters, strength athletes): Ipamorelin's longer half-life and selectivity make it easier to time around training and sleep without adding cortisol or prolactin noise.

Side-effect profile

Both are tolerated well at standard doses. The main differences:

• Sermorelin: Can cause flushing or mild headache in the first week. Injection-site reactions are uncommon.
• Ipamorelin: Cleaner side-effect profile than other GHRPs (no GHRP-2/GHRP-6 hunger-and-cortisol issue). Some users report mild hand numbness or tingling at higher doses — a sign of GH overshoot, not toxicity.

Both can produce water retention and joint aches in the first 2–4 weeks of a cycle. Both can elevate fasting glucose modestly. See the GH secretagogues pillar for the full side-effect breakdown.

How they're typically dosed

Sermorelin — 200–500 mcg subQ, usually before bed. Sometimes split into two daily doses.

Ipamorelin — 200–300 mcg subQ, 1–3 times daily, often combined with 100–200 mcg CJC-1295 (no DAC) or 1–2 mg CJC-1295 DAC weekly.

The "best" timing for both is empty stomach, away from meals — food blunts the GH pulse. Pre-bed dosing is most common because GH and sleep share a circadian relationship.

What to do

If you're new to GH secretagogues, the typical starting move is:

1. Pick a goal — recovery, sleep, body composition — that defines the protocol
2. Decide on the channel — prescription (sermorelin route is easier) or research-chemical (ipamorelin + CJC-1295 dominates)
3. Run one stack at a time — don't combine sermorelin with ipamorelin and CJC-1295 in your first cycle; you won't know what's working
4. 8–12 week cycles — long enough to evaluate, short enough to avoid receptor desensitization. See cycling peptides forever for context.

Related questions

• Hand numbness on ipamorelin: why?
• Joints ache on a GH cycle?
• GH secretagogues pillar
• Water retention on GH peptides